FF2039
FF2039 (compound 1j) is a specific HDAC1, HDAC6, and HDAC isoforms of class I, IIa and IIb PROTAC degrader. FF2039 demonstrates s significant antiproliferative activity against both hematological and solid cancer cell lines, driven by cell cycle arrest and Apoptosis induction. FF2039 inhibits HDAC isoform of HDAC1, HDAC2, HDAC4 and HDAC6 with IC50s of 1.03, 2.15, 12.4 and 0.053 μM, respectively. FF2039 shows antiproliferative activity against different tumor entities of MM.1S, MDA-MB-231 and U-87MG with EC50s of 2.8, 28 and 30 μM, respectively. (Pink: PRMT5 ligand (HY-168864); Blue: E3 ligase ligand HY-W957284); Black: linker (HY-W881439); E3+linker (HY-172185 )).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C43H56Cl3N5O6
- Masse moléculaire:845.29
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
|
HDAC1 1.03 μM (IC50) |
HDAC2 2.15 μM (IC50) |
HDAC4 12.4 μM (IC50) |
HDAC6 0.053 μM (IC50) |
Chemical Information
-
Masse moléculaire 845.29
-
Formule C43H56Cl3N5O6
-
SMILES
O=C(NCCCCCCC(NO)=O)C1=CC=C(NC(CCCCCCCCCCCN(C(C2=CC=C(Cl)C(Cl)=C2)C(NCC3=CC=CC=C3)=O)C(CCl)=O)=O)C=C1
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)